Equity Overview
Price & Market Data
Price: $5.56
Daily Change: +$0.03 / 0.54%
Daily Range: $5.30 - $5.70
Market Cap: $51,907,676
Daily Volume: 38,027
Performance Metrics
1 Week: 18.80%
1 Month: -11.18%
3 Months: 20.87%
6 Months: 39.52%
1 Year: 23.97%
YTD: -26.55%
Company Details
Employees: 26
Sector: Health technology
Industry: Biotechnology
Country:
Details
LeonaBio, Inc., clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. Its product pipeline includes ATH-1105 for the treatment of amyotrophic lateral sclerosis, which is in phase 1 clinical trial; ATH-1020 for the treatment of neurodegenerative diseases, which is phase 1 clinical trial, as well as early compounds which is in preclinical phase. The company was formerly known as Athira Pharma, Inc. and changed its name to LeonaBio, Inc. in January 2026. LeonaBio, Inc. was incorporated in 2011 and is headquartered in Bothell, Washington.